Kopp LeRoy C »

Miragen Therapeutics shares owned by Kopp LeRoy C

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Kopp LeRoy C from 13F filings

Historical chart of Kopp LeRoy C investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Kopp LeRoy C consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Kopp LeRoy C

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.6M 206k 17.51

More positions owned by Kopp LeRoy C

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Russell 2000 Etf (IWM)
Vericel (VCEL)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Five9 (FIVN)
NeoGenomics Com New (NEO)
Atlassian Corp Cl A
Inspire Med Sys (INSP)
Jamf Hldg Corp (JAMF)
Workiva Com Cl A (WK)
Model N (MODN)
Miragen Therapeutics (VRDN)
Mitek Sys Com New (MITK)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Kopp LeRoy C

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
VR Adviser
Deep Track Capital
Fairmount Funds Management
Paradigm Biocapital Advisors
Perceptive Advisors
Commodore Capital
Kynam Capital Management
Novo A/S
State Street Corporation
Tang Capital Management
Alliancebernstein
Maverick Capital

View all funds holding Miragen Therapeutics